Abhiram Natu, PhD
Postdoctoral Associate in the Child Study CenterDownloadHi-Res Photo
About
Titles
Postdoctoral Associate in the Child Study Center
Appointments
Child Study Center
Postdoctoral AssociatePrimary
Other Departments & Organizations
Education & Training
- PhD
- Advanced Centre for Treatment Research Education in Cancer, Epigenetics and Chromatin Biology
Research
Research at a Glance
Publications Timeline
A big-picture view of Abhiram Natu's research output by year.
8Publications
Publications
Featured Publications
Mitochondrial dysfunction and chromatin changes with autophagy-mediated survival in doxorubicin resistant cancer cell lines.
Natu A, Pedgaonkar A, Gupta S. Mitochondrial dysfunction and chromatin changes with autophagy-mediated survival in doxorubicin resistant cancer cell lines. Biochem Biophys Res Commun 2023, 648: 1-10. PMID: 36724554, DOI: 10.1016/j.bbrc.2023.01.081.Peer-Reviewed Original ResearchHepatocellular carcinoma: Understanding molecular mechanisms for defining potential clinical modalities.
Natu A, Singh A, Gupta S. Hepatocellular carcinoma: Understanding molecular mechanisms for defining potential clinical modalities. World J Hepatol 2021, 13: 1568-1583. PMID: 34904030, DOI: 10.4254/wjh.v13.i11.1568.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsHistone acetylation: a key determinant of acquired cisplatin resistance in cancer.
Natu A, Verma T, Khade B, Thorat R, Gera P, Dhara S, Gupta S. Histone acetylation: a key determinant of acquired cisplatin resistance in cancer. Clin Epigenetics 2024, 16: 8. PMID: 38172984, DOI: 10.1186/s13148-023-01615-5.Peer-Reviewed Original ResearchIntegrative epigenome-transcriptome analysis unravels cancer-specific over-expressed genes potentially regulating immune microenvironment in clear cell renal cell carcinoma.
Gadewal N, Natu A, Sen S, Rauniyar S, Bastikar V, Gupta S. Integrative epigenome-transcriptome analysis unravels cancer-specific over-expressed genes potentially regulating immune microenvironment in clear cell renal cell carcinoma. Biochim Biophys Acta Gen Subj 2024, 1868: 130596. PMID: 38471632, DOI: 10.1016/j.bbagen.2024.130596.Peer-Reviewed Original Research
2023
An increase in polyadenylation of histone isoforms, Hist1h2ah and Hist2h3c2, is governed by 3'-UTR in de-differentiated and undifferentiated hepatocyte.
Verma T, Natu A, Khade B, Gera P, Gupta S. An increase in polyadenylation of histone isoforms, Hist1h2ah and Hist2h3c2, is governed by 3'-UTR in de-differentiated and undifferentiated hepatocyte. Exp Biol Med (Maywood) 2023, 248: 948-958. PMID: 37021545, DOI: 10.1177/15353702231160328.Peer-Reviewed Original Research
2021
RPS13, a potential universal reference gene for normalisation of gene expression in multiple human normal and cancer tissue samples.
Rashid M, Shah SG, Natu A, Verma T, Rauniyar S, Gera PB, Gupta S. RPS13, a potential universal reference gene for normalisation of gene expression in multiple human normal and cancer tissue samples. Mol Biol Rep 2021, 48: 7967-7974. PMID: 34657252, DOI: 10.1007/s11033-021-06828-6.Peer-Reviewed Original ResearchIn-Silico Analysis of Chromatin Modifiers and Profiling of Histone Deacetylases (HDAC's) in Human Oral Cancer.
Sajnani AK, Shah SG, Rashid M, Natu A, Gera PB, Gupta S. In-Silico Analysis of Chromatin Modifiers and Profiling of Histone Deacetylases (HDAC's) in Human Oral Cancer. Chonnam Med J 2021, 57: 176-184. PMID: 34621637, DOI: 10.4068/cmj.2021.57.3.176.Peer-Reviewed Original Research
2020
HISTome2: a database of histone proteins, modifiers for multiple organisms and epidrugs.
Shah SG, Mandloi T, Kunte P, Natu A, Rashid M, Reddy D, Gadewal N, Gupta S. HISTome2: a database of histone proteins, modifiers for multiple organisms and epidrugs. Epigenetics Chromatin 2020, 13: 31. PMID: 32746900, DOI: 10.1186/s13072-020-00354-8.Peer-Reviewed Original Research